Literature DB >> 28359234

Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents.

Siddappa A Patil1, Vikrant Patil1, Renukadevi Patil2, Kenneth Beaman3, Shivaputra A Patil4.   

Abstract

BACKGROUND: Discovery of novel antiviral agents is essential because viral infection continues to threaten human life globally. Various heterocyclic small molecules have been developed as antiviral agents. The 5,6-dimethoxyindan-1-on nucleus is of considerable interest as this ring is the key constituent in a range of bioactive compounds, both naturally occurring and synthetic, and often of considerable complexity.
OBJECTIVE: The main purpose of this research was to discover and develop small molecule heterocycles as broad-spectrum of antiviral agents.
METHOD: A focused small set of 5,6-dimethoxyindan-1-one analogs (6-8) along with a thiopene derivative (9) was screened for selected viruses (Vaccinia virus - VACA, Human papillomavirus - HPV, Zika virus - ZIKV, Dengue virus - DENV, Measles virus - MV, Poliovirus 3 - PV, Rift Valley fever virus - RVFV, Tacaribe virus - TCRV, Venezuelan equine encephalitis virus - VEEV, Herpes simplex virus 1 -HSV-1 and Human cytomegalovirus - HCMV) using the National Institute of Allergy and Infectious Diseases (NIAID)'s Division of Microbiology and Infectious Diseases (DMID) antiviral screening program.
RESULTS: These molecules demonstrated moderate to excellent antiviral activity towards variety of viruses. The 5,6-dimethoxyindan-1-one analog (7) demonstrated high efficacy towards vaccinia virus (EC50: <0.05 µM) and was nearly 232 times more potent than the standard drug Cidofovir (EC50: 11.59 µM) in primary assay whereas it demonstrated moderate activity (EC50: >30.00 µM) in secondary plaque reduction assay. The thiophene analog (9) has shown very good viral inhibition towards several viruses such as Human papillomavirus, Measles virus, Rift Valley fever virus, Tacaribe virus and Herpes simplex virus 1.
CONCLUSION: Our research identified a novel 5,6-dimethoxyindan-1-one analog (compound 7), as a potent antiviral agent for vaccinia virus, and heterocyclic chalcone analog (compound 9) as a broad spectrum antiviral agent. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  5; 6-Dimethoxyindan-1-one; HIV; NIAID; antiviral; in vitro screening; ketone; virus

Mesh:

Substances:

Year:  2017        PMID: 28359234     DOI: 10.2174/1573406413666170330094822

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  5 in total

Review 1.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

2.  In vitro and in silico insights into tyrosinase inhibitors with (E)-benzylidene-1-indanone derivatives.

Authors:  Hee Jin Jung; Sang Gyun Noh; Yujin Park; Dongwan Kang; Pusoon Chun; Hae Young Chung; Hyung Ryong Moon
Journal:  Comput Struct Biotechnol J       Date:  2019-08-01       Impact factor: 7.271

3.  Structural Modifications and Biological Evaluations of Rift Valley Fever Virus Inhibitors Identified from Chemical Library Screening.

Authors:  Koushikul Islam; Marcus Carlsson; Per-Anders Enquist; Weixing Qian; Marko Marttila; Mårten Strand; Clas Ahlm; Magnus Evander
Journal:  ACS Omega       Date:  2022-02-16

Review 4.  Discovery and development of safe-in-man broad-spectrum antiviral agents.

Authors:  Petter I Andersen; Aleksandr Ianevski; Hilde Lysvand; Astra Vitkauskiene; Valentyn Oksenych; Magnar Bjørås; Kaidi Telling; Irja Lutsar; Uga Dumpis; Yasuhiko Irie; Tanel Tenson; Anu Kantele; Denis E Kainov
Journal:  Int J Infect Dis       Date:  2020-02-17       Impact factor: 3.623

5.  Synthesis, In Silico and In Vitro Evaluation for Acetylcholinesterase and BACE-1 Inhibitory Activity of Some N-Substituted-4-Phenothiazine-Chalcones.

Authors:  Thai-Son Tran; Minh-Tri Le; Thi-Cam-Vi Nguyen; The-Huan Tran; Thanh-Dao Tran; Khac-Minh Thai
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.